muraglitazar has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cap, M; Chang, C; Cheng, PT; Chu, C; Devasthale, P; Doweyko, AM; Farrelly, D; Gu, L; Hariharan, N; Harrity, T; Hosagrahara, V; Kadiyala, P; Kunselman, L; Lippy, J; Locke, K; Morgan, N; Muckelbauer, J; O'Malley, K; Ponticiello, R; Ryono, D; Wang, W; Zahler, R; Zebo, R; Zhang, L | 1 |
| Belder, R; Chen, S; Cheng, PT; Devasthale, P; Egan, D; Farrelly, D; French, M; Gu, L; Hariharan, N; Harrity, T; Janovitz, E; Kunselman, L; Peters, A; Ponticiello, R; Staal, A; Swartz, J; Taylor, S; Tozzo, E; Welzel, G; Whaley, J; Zebo, R | 1 |
2 other study(ies) available for muraglitazar and Alloxan Diabetes
| Article | Year |
|---|---|
Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists.
Topics: Administration, Oral; Animals; Azetidines; Biological Availability; Copper; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Experimental; Dyslipidemias; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glucose; Mice; Mice, Mutant Strains; Molecular Structure; PPAR alpha; PPAR gamma; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Triglycerides | 2008 |
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
Topics: Animals; Body Weight; C-Peptide; Diabetes Mellitus, Experimental; Disease Progression; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glycine; Hypoglycemic Agents; Insulin; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Oxazoles; Pancreas; PPAR alpha; PPAR gamma; Triglycerides | 2007 |